About Rolamed

Founder-led. Specialist-backed. Built around the mandate.

Rolamed provides senior advisory and leadership to organisations where healthcare, technology, regulation, strategy and commercial execution intersect.

The model

One point of accountability. A broader depth of expertise.

Every Rolamed engagement is led through Dr. Julio Guerrero Ontiveros. Around that relationship, specialist expertise can be assembled according to the needs of the assignment.

The model gives clients direct access to senior judgement without requiring them to coordinate multiple independent specialists themselves.

We don't sell headcount. We bring the right experience to the problem.

Founder

Medical background. Executive experience. MedTech focus.

Julio is a medical doctor and MedTech executive with more than a decade of senior leadership experience. His background spans medical-device innovation, product development, clinical strategy, regulatory pathways, fundraising, operations and commercialisation.

Medical insight

Clinical training and experience informing product, evidence, healthcare and patient-centred decisions.

Executive leadership

Experience leading organisations, operations, partnerships, governance and growth in regulated environments.

MedTech execution

Hands-on experience across development, quality, regulatory submissions, funding and market entry.

Specialist network

Deep expertise without a public roster.

Rolamed works with senior specialists whose expertise spans regulatory affairs, corporate finance, product and industrial design, human factors, software, firmware and other medical-sector disciplines. Many hold demanding positions within leading universities and global organisations, so their involvement is kept discreet and engagement-specific.

For clients, the practical result is simple: a single senior relationship with access to the specialist capability required by the mandate.

Experience

Trusted in confidential environments.

Rolamed has supported private hospitals and clinics, medical-device and R&D businesses, universities and public-sector organisations. Client names and sensitive project details are not published as marketing collateral.